Medical News

RSS

DFG to establish eight new CRCs as of 1 January 2012

The Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) will establish eight Collaborative Research Centres (CRC) as of 1 January 2012. This was agreed by the responsible Grants Committee at its autumn meeting in Bonn.

5 Dec 2011

Enrollment commences in Estech's HISTORIC-AF staged hybrid ablation study

Estech, a leader in minimally invasive cardiac surgery, announced today that the first three patients have been enrolled in the HISTORIC-AF European multi-center staged hybrid ablation clinical study.

5 Dec 2011

Biogen, Samsung partner to develop and market biosimilars

Samsung and Biogen Idec today announced that they have entered into an agreement to invest $300 million to establish a joint venture to develop, manufacture and market biosimilars. Samsung will take a leading role in the joint venture, with Biogen Idec contributing its expertise in protein engineering and biologics manufacturing.

5 Dec 2011

EnVivo presents positive EVP-6124 Phase 2b trial data on schizophrenia at 50th ACNP meeting

EnVivo Pharmaceuticals, a company dedicated to developing a broad range of novel central nervous system (CNS) therapies, announced today that it is presenting the comprehensive analysis of a recently completed Phase 2b clinical trial of EVP-6124, a novel, orally bioavailable nicotinic alpha-7 agonist, in schizophrenia at the American College of Neuropsychopharmacology 50th Anniversary Annual Meeting.

5 Dec 2011

Viewpoints: Premium support disadvantages; GOP candidates & the individual mandate; Stop fight over high court recusals?

Republican politicians are touting the virtues of market competition and calling for a "premium support" plan that would give beneficiaries a set amount of money to shop among private plans for their own insurance. What they do not say is that private plans have long been more costly than traditional Medicare and have shown far less ability to slow spending.

5 Dec 2011

Fatal snakebites emerging global threat

Fatal snakebites are a bigger-than-acknowledged global health problem that has been vastly under-reported, according to research presented today at the American Society of Tropical Medicine and Hygiene’s (ASTMH) annual meeting.

5 Dec 2011

Alcohol related liver problems on the rise among the young

According to the NHS figures there has been a huge increase in the number of young adults treated in hospital for serious liver problems brought on by drinking too much.

5 Dec 2011

Obesity maybe passed down from fathers to kids: Study

Australian researchers have found that the sperm of overweight fathers appears to carry a molecular signal that causes their offspring to inherit obesity. This may be more severe in female children and males they add.

5 Dec 2011

Stem cells for the damaged heart

Stem cell research got its latest boost. For the first time, stem cells were injected into the hearts of humans who had suffered serious heart damage, and patients improved dramatically. The scientists found that the stem cells grew into new heart cells to replace the damaged tissue.

5 Dec 2011

Measles raises its head again in Europe after years of suppression: Report

According to a new report last Thursday, measles incidence is on the rise in Europe following decades of decline. Up to October European health officials reported more than 26,000 measles cases this year and nine deaths.

5 Dec 2011

Herzig Eye Institute named TearScience's first Center of Excellence

TearScience, Inc., a privately-held medical device company, today announced Toronto-based Herzig Eye Institute, one of the leading authorities in laser vision correction and advanced cataract and refractive surgery, as its first Center of Excellence.

5 Dec 2011

MRG releases 2012 report on European markets for large-joint reconstructive implants

According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, the European market for large-joint reconstructive implants will grow moderately through 2016.

5 Dec 2011

Competition among institutions for doctors, scientists grabs headlines

Some big name health facilities sometimes draw entire physician or research groups from other institutions.

5 Dec 2011

Premier healthcare alliance awards new agreement for specialty distribution-research

The Premier healthcare alliance today announced a new agreement for specialty distribution-research has been awarded to VWR International, LLC, a global laboratory supply and distribution company with worldwide sales in excess of $3.6 billion in 2010.

5 Dec 2011

Factors associated with increased risk of in-hospital falls after total hip or knee replacement surgery

Investigators from Hospital for Special Surgery have identified factors that are associated with an increased risk of in-hospital falls after total hip or knee replacement surgery.

5 Dec 2011

Medicare 'doc fix' on Congress' to-do list

News outlets report on Congress' pivotal week ahead, which could include an extension of the payroll tax break and a patch to prevent a scheduled cut in Medicare physician payments.

5 Dec 2011

Wolters Kluwer Health announces acquisition of STM journal publisher in India, Medknow

Wolters Kluwer Health today announced that it has acquired Medknow PVT Ltd., a leading Scientific, Technical & Medical (STM) journal publishing operation headquartered in Mumbai, India and one of the largest open access publishers in the world.

5 Dec 2011

Towards a national plan of action for rare diseases

"Rare diseases", by their very definition, occur in no more than 5 people out of every 10,000 inhabitants. Barely noticed by the general public, only around 1,000 of the currently 6,000 or so different rare diseases currently listed on the Internet platform Orphanet are treatable nowadays.

5 Dec 2011

Veterans' access to mental health services remains a concern

Access questions and concerns are deepening as more men and women end their tours of duty and need therapy upon returning to the U.S. In other news, NPR reports on the debate surrounding the costs of military retiree benefits.

5 Dec 2011

Preliminary top-line results from XenoPort's XP21279 Phase 2 trial for advanced Parkinson’s disease

XenoPort, Inc. announced today preliminary top-line results of a Phase 2, randomized, crossover clinical trial that compared optimized treatment with either Sinemet (immediate-release levodopa/carbidopa) or XP21279 co-formulated with carbidopa (279/CD) in advanced Parkinson's disease patients with motor fluctuations.

5 Dec 2011